Myeloid cell-specific β2-adrenergic receptor deletion improves early cardiac injury resolution via de-repression of Anxa1
Theranostics · 2026
DOI: 10.7150/thno.123651 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2026. Verfasst von Tapas K Nayak und 8 weiteren Autor:innen. Beteiligte Einrichtung: Aging + Cardiovascular Discovery Center, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA, 19140. Hauptthemen laut MEDLINE: Receptors, Adrenergic, beta-2, Myeloid Cells, Myocardial Infarction, Annexin A1. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, BLRD VA.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Aging + Cardiovascular Discovery Center, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA, 19140.
- Department of Medicine, University of California at Los Angeles, CA, USA, 90095.
Förderung
- NHLBI NIH HHS
- BLRD VA
Zitieren
APA
Nayak, T. K., Bajpai, A., Patwa, V., Carter, R. L., Enjamuri, N., Gao, E., Rajan, S., Xiang, Y. K., & Tilley, D. G. (2026). Myeloid cell-specific β2-adrenergic receptor deletion improves early cardiac injury resolution via de-repression of Anxa1. Theranostics. https://doi.org/10.7150/thno.123651
Vancouver
Nayak TK, Bajpai A, Patwa V, Carter RL, Enjamuri N, Gao E, et al. Myeloid cell-specific β2-adrenergic receptor deletion improves early cardiac injury resolution via de-repression of Anxa1. Theranostics. 2026. doi:10.7150/thno.123651
BibTeX
@article{Nayak2026,
author = {Nayak, Tapas K and Bajpai, Anamika and Patwa, Viren and Carter, Rhonda L and Enjamuri, Nitya and Gao, Erhe and Rajan, Sudarsan and Xiang, Yang K and Tilley, Douglas G},
title = {Myeloid cell-specific β2-adrenergic receptor deletion improves early cardiac injury resolution via de-repression of Anxa1},
journal = {Theranostics},
year = {2026},
doi = {10.7150/thno.123651}
}
EUVIMED